Camlin Fine Sciences Ltd Share Price – NSE /  BSE

Chemicals, Small Cap

As per the disclosure, the pledge was created on 24 February 2026 in favour of HDFC Bank to facilitate borrowing by the company.

Following the transaction, the total number of shares encumbered by Ashish Dandekar stands at 88,00,000 shares, representing 4.58% of the company?s total equity. Prior to this, 70,00,000 shares, or 3.64% of the equity, were already pledged.

Ashish Dandekar holds 1,97,78,510 shares in the company, accounting for 10.30% of the total share capital, with about 44.5% of his personal holding currently pledged.

As of December 2025, promoters collectively held 48.03% in the company. The latest pledge alone represents 0.94% of the company's total equity.

Camlin Fine Sciences is a specialty chemicals company engaged in the research, development, manufacturing and marketing of a diversified portfolio spanning shelf-life solutions, aroma ingredients, performance chemicals, and health and wellness products, catering to multiple industrial and consumer segments.

On a consolidated basis, Camlin Fine Sciences reported net loss of Rs 36.23 crore in Q3 December 2025 as against net loss of Rs 4.14 crore in Q3 December 2024. Net sales rose 6.07% YoY to Rs 457.20 crore in Q3 December 2025.

Shares of Camlin Fine Sciences surged 6.72% to settle at Rs 148.50 on Friday, 27 February 2026.

Powered by Capital Market - Live News

Net Loss of Camlin Fine Sciences reported to Rs 36.23 crore in the quarter ended December 2025 as against net loss of Rs 4.14 crore during the previous quarter ended December 2024. Sales rose 6.07% to Rs 457.20 crore in the quarter ended December 2025 as against Rs 431.02 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 13 February 2026.

Powered by Capital Market - Live News

Net Loss of Camlin Fine Sciences reported to Rs 14.38 crore in the quarter ended September 2025 as against net loss of Rs 100.23 crore during the previous quarter ended September 2024. Sales rose 10.19% to Rs 459.83 crore in the quarter ended September 2025 as against Rs 417.32 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News